Arrowhead Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Arrowhead Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Arrowhead Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrowhead Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $44M | 663k | 66.39 |
| 2025-09-30 | $4.3M | 125k | 34.49 |
| 2022-12-31 | $703k | 17k | 40.56 |
| 2022-09-30 | $1.5M | 47k | 33.05 |
| 2022-06-30 | $3.1M | 87k | 35.21 |
| 2022-03-31 | $3.1M | 67k | 45.99 |
| 2021-12-31 | $2.1M | 32k | 66.32 |
| 2021-09-30 | $4.1M | 66k | 62.43 |
| 2021-06-30 | $2.9M | 35k | 82.81 |
| 2017-06-30 | $159k | 98k | 1.62 |
| 2017-03-31 | $48k | 26k | 1.84 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management